Dr. Chan obtained his medical degree from the Chinese University of Hong Kong in 1998. He has joined the Department of Surgery, Prince of Wales Hospital since 1999 and has held the fellowships from the Royal College of Surgeons of Edinburgh, the College of Surgeons of Hong Kong and Doctoral Degree in Medicine (CUHK). In 2008, Dr. Chan completed his fellowship in Lerner Research Institute, Cleveland Clinic Foundation, US. His interest in urology includes laparoscopic/robotic urologic surge ry and translational bladder cancer research. In basic research, Dr Chan developed a mouse orthotopic bladder cancer model and studied the anti-angiogenic therapy in bladder cancer. Currently, Dr Chan is the Clinical Associate Professor (Honorary) of the Chinese University of Hong Kong and the Consultant of the Division of Urology in the Prince of Wales Hospital. He is the president of Hong Kong Society of Endourology and honorary secretary of Hong Kong Urological Association.
Education and Faculty Appointments
1984, Surgeon, Department of Urology, Zhujiang Hospital
1991, M.D, Sun Yet-sun Medical Collegue
1995, Associate professor, Chief of Department of Urology, Zhujiang Hospital
1998, Chief, Department of Urology, Zhujiang Hospital
2003, Visiting doctor, Norris center, USC, U.S
2014, Visiting doctor,Jefferson Memorial Hospital,U.S
Henry Woo - MBBS DMedSc FRACS(Urol) - is Professor of Surgery at the Sydney Adventist Hospital Clinical School of the University of Sydney. He is also the Director of Uro-Oncology and the Professor of Robotic Cancer Surgery at the Chris O’Brien Lifehouse cancer centre in Sydney. He is on the Board of Directors of the Australian and New Zealand Uro-genital and Prostate Cancer Trials Group (ANZUP) as well as the Australian Urological Foundation (AUF). He is an Associate Editor of the journal Prostate Cancer and Prostatic Diseases and serves on the editorial boards of European Urology, BJUI, Asian Journal of Urology and Prostate International. He has published over 140 peer reviewed manuscripts and several book chapters. In addition to broad research interests in BPH and prostate cancer, he has interests in urological education and professionalism in surgery. He is the coordinator of the International Urology Journal Club on Twitter and is the Founder and Chair of the Urology Green List. Outside of urology, his interests include retro technology such as turntables, 45rpm jukeboxes and 35mm cameras, as well vinyl record collecting and live music.
Dr Mototsugu Oya obtained his medical degree (1987) and his Ph.D. (1994) from the Keio University School of Medicine, Japan. Dr Oya studied at the Department of Urology, New York Medical College, USA (1995-1996), and Department of Urology, Dusseldorf University, Germany (1997-1998). He is currently the Professor and Chairman, Department of Urology, Keio University School of Medicine and also holds Vice Director, Keio University Hospital. Additionally, Dr Oya has published extensively over 294 publications in high impact scientific journals. He joins in various Editorial Boards such as International Journal of Urology, Cancer Science, International Case Conference Journal, Clinical and Experimental Nephrology, World Journal of Urology, International Journal Clinical Oncology, and the Japanese Journal of Clinical Oncology. He is an emeritus editor-in-chief of International Journal of Urology. He was awarded the Japan Urology Association Award (2005). He recently published the book titled Renal Cell Carcinoma-Molecular Features and Treatment Updates-, Springer (2017).